Other
Debt Repayments
Gilead Sciences Debt Repayments increased by 34475.0% to $2.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 57.0%, from $1.76B to $2.77B. Over 3 years (FY 2021 to FY 2025), Debt Repayments shows a downward trend with a -27.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryLeverage
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Higher repayments indicate a focus on reducing leverage and interest expense, which is generally viewed positively by creditors.
Detailed definition
Cash outflows used to pay down the principal amount of outstanding debt obligations. This metric demonstrates the firm's...
Peer comparison
Standard financing activity for any company with outstanding debt.
Metric ID:
other_repayments_of_debtHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $2.50B | $1.00B | $500.00M | $1.00B | $0.00 | $0.00 | $2.25B | $0.00 | $0.00 | $1.85B | $112.00M | $7.00M | $1.76B | $9.00M | $9.00M | $8.00M | $2.77B |
| QoQ Change | — | — | -60.0% | -50.0% | +100.0% | -100.0% | — | — | -100.0% | — | — | -93.9% | -93.8% | >999% | -99.5% | +0.0% | -11.1% | >999% |
| YoY Change | — | — | — | — | -60.0% | -100.0% | — | +125.0% | — | — | — | -95.0% | — | — | -99.5% | -92.0% | +14.3% | +57.0% |
Range$0.00 – $2.77B
Avg YoY Growth-31.3%
Median YoY Growth-76.0%
Debt Repayments at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's debt repayments?
- Gilead Sciences (GILD) reported debt repayments of $2.77B in Q1 2026.
- How has Gilead Sciences's debt repayments changed year-over-year?
- Gilead Sciences's debt repayments increased by 57.0% year-over-year, from $1.76B to $2.77B.
- What is the long-term trend for Gilead Sciences's debt repayments?
- Over 3 years (2021 to 2025), Gilead Sciences's debt repayments has grown at a -27.8% compound annual growth rate (CAGR), from $4.75B to $1.79B.
- What does debt repayments mean?
- Cash spent to pay back borrowed money.